Imperial College London

ProfessorPeterSever

Faculty of MedicineNational Heart & Lung Institute

Professor of Clinical Pharmacology & Therapeutics
 
 
 
//

Contact

 

+44 (0)20 7594 1099p.sever

 
 
//

Assistant

 

Mrs Yvonne Green +44 (0)20 7594 1100

 
//

Location

 

333ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Marston:2020:10.1161/CIRCULATIONAHA.120.046397,
author = {Marston, NA and Gurmu, Y and Melloni, GEM and Bonaca, M and Gencer, B and Sever, PS and Pedersen, TR and Keech, AC and Roselli, C and Lubitz, SA and Ellinor, PT and O'Donoghue, ML and Giugliano, RP and Ruff, CT and Sabatine, MS},
doi = {10.1161/CIRCULATIONAHA.120.046397},
journal = {CIRCULATION},
pages = {1600--1607},
title = {The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism},
url = {http://dx.doi.org/10.1161/CIRCULATIONAHA.120.046397},
volume = {141},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Marston,NA
AU - Gurmu,Y
AU - Melloni,GEM
AU - Bonaca,M
AU - Gencer,B
AU - Sever,PS
AU - Pedersen,TR
AU - Keech,AC
AU - Roselli,C
AU - Lubitz,SA
AU - Ellinor,PT
AU - O'Donoghue,ML
AU - Giugliano,RP
AU - Ruff,CT
AU - Sabatine,MS
DO - 10.1161/CIRCULATIONAHA.120.046397
EP - 1607
PY - 2020///
SN - 0009-7322
SP - 1600
TI - The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
T2 - CIRCULATION
UR - http://dx.doi.org/10.1161/CIRCULATIONAHA.120.046397
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536791300007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 141
ER -